Mats H Wikstroem

Title: Innovations of Mats H. Wikstroem in Biopharmaceuticals

Introduction

Mats H. Wikstroem is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the area of protein analysis. His innovative approaches have the potential to enhance the development and formulation of therapeutic products.

Latest Patents

Mats H. Wikstroem holds a patent for "Methods of fingerprinting therapeutic proteins via a two-dimensional (2D) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products." This patent outlines methods for fingerprinting specific molecules in a composition using nuclear magnetic resonance (NMR). The disclosed NMR methods provide several modifications and improvements over existing techniques. In some embodiments, the methods include applying a cycle of signal processing steps, which consist of applying a radio frequency (RF) pulse, a gradient pulse with a pulse length of less than or equal to 1000 μs, and a water suppression technique (WET). The methods further include repeating the cycle at least three times to acquire an enhanced signal of the composition, which is then used for fingerprinting the specific molecule.

Career Highlights

Mats H. Wikstroem has established himself as a key figure in the biopharmaceutical industry. He is currently associated with Amgen Inc., where he continues to innovate and contribute to the advancement of therapeutic protein analysis. His work is instrumental in improving the quality and efficacy of biopharmaceutical products.

Collaborations

Mats has collaborated with Tsang-Lin Hwang, further enhancing the research and development efforts in their field. Their combined expertise has led to advancements in the methodologies used for protein analysis.

Conclusion

Mats H. Wikstroem's contributions to the field of biopharmaceuticals through his innovative patent demonstrate his commitment to advancing therapeutic protein analysis. His work not only enhances the understanding of biopharmaceutical products but also paves the way for future innovations in the industry.